| Metric | Value (₹ Cr) | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue | 1.0K | 33.7% | 32.0% |
| Total Income | 1.1K | 33.0% | 33.9% |
| Expenditure | 723.88 | 5.4% | 6.9% |
| PBT | 351.71 | 189.7% | 179.5% |
| Net Profit | 295.55 | 424.4% | 201.3% |
| OPM | 37.10% | 17.65pp | 15.11pp |
| NPM | 27.48% | 20.51pp | 15.27pp |
| EPS | 21.71 | 265.5% | 237.6% |
Strong Q2, core growth softer than headline; reaffirm 18%+ margins
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade A
H1 11% growth within 10–20% guidance. Q2 PAT (₹296 Cr) and revenue (₹1,035 Cr) matched actuals. 18%+ margin guidance met (H1 macro 33.7% incl. gains, core ~20%). No prior guidance missed.
Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong Q2 headline (32% growth, 201% PAT) is propped by ₹194 Cr one-off gain; core EBITDA margin ~20–22%, not 39.5%. H1 actual 11% growth trails midpoint of 10–20% guidance. Execution track record credible, order book ₹2,279 Cr provides 1.8-year visibility, but near-term dependent on Pune-Shirur appointed date (Q4) and Aunta-Simaria close (Q3). Risk: if capex cycle delays, FY27 revenue growth likely undershoots 15% midpoint.
₹1034.6 Cr
Revenue · +32% YoY₹295.6 Cr
Reported PAT · +201.3% YoYExpanding
Margins · vs guidance: CorroboratedDid the claims hold up?
Q2 revenue ₹1,035 Cr, 32% YoY growth
METDelivered ₹1,034.6 Cr, 32.0% YoY; core ops inflated by ₹194 Cr gain from Mukarba stake sale
Q2 PAT ₹296 Cr, 201% YoY growth
METDelivered ₹295.6 Cr, 201.3% YoY; includes ₹194 Cr one-off gain (core PAT ~₹102 Cr)
H1 FY27 revenue ₹1,808 Cr, 11% YoY; EBITDA ₹610 Cr, 53% YoY
METQ1+Q2 math: (1,035-194+offset) ≈ 1,808 Cr implies Q1 core ops ~₹967 Cr; 11% growth plausible if Q1 prior-year was ~₹876 Cr
Order book ₹995 Cr from DGT covers ~3 years of revenue at current run rate
OVERSTATED₹995 Cr / annualized Q2 run rate (1,035×4≈4,140 Cr) = ~9 months, not 3 years
Maintaining 18%+ EBITDA margin guidance despite cost pressures
METH1 EBITDA margin ~33.7% (610/1,808) excl. one-offs; core margin ~20%–22% after backing out ₹194 Cr gain impact
Earnings quality
What changed since the last call
Revenue growth guidance widened
UpgradeQ1 call: narrowed to 15%. Q2 call: reverted to original 10–20% range (upper bound 15% → 20%); but H1 actual 11% suggests closer to lower end
Order book addition target
NeutralAiming to add ₹1,000–1,100 Cr to ₹2,279 Cr base to reach INR8,000–10,000 Cr guidance (full order book, not just adds)
Capex recycling milestone
NewAunta-Simaria monetization (₹200 Cr equity sale) expected Q3; frees capital for Pune-Shirur and water project expansion
Gas project advancement
NewDGT/AWEL facility order passed by DGH; capital cost reduced by ~$300–400 M vs. original plan; EDP submitted, approval pending
The Q&A
Anand Darshan pressed on WMEL underperformance (₹320 Cr H1 vs. ₹1,000 Cr full-year), DGT deal structure and revenue potential, and order pipeline. Mgmt held firm on guidance (10–20%, 18%+ margin) but withheld specific DGT revenue/margin numbers citing confidentiality. Pramod Kumar and Srika verified order guidance and Pune-Shirur revenue range; mgmt answered confidently. Overall: moderate pressure, mgmt held line, no guidance cut or major concessions.
DGT oil-gas project — Anand Darshan
PartialFacilities starting from B-12-11P platform (30 km from shore), pipeline to TCPP for processing. Capital cost reduced by ~$300–400 M via existing infrastructure reuse. Revenue depends on 0.6 Tcf gas + 2M barrels oil condensate; pricing TBD. EDP submitted to DGH, approval pending. Confidential on exact numbers.
WMEL division revenue — Anand Darshan
PartialYear-on-year moderation reflects timing of order releases. Orders released now, moving to convert. Optimistic about H2. May match or exceed prior ₹1,000 Cr guidance.
Full-year order intake — Anand Darshan
AnsweredSticking with INR8,000–10,000 Cr order addition for full year (consolidated). WMEL specifically expects ₹700–1,200 Cr orders in H2.
Revenue growth guidance — Pramod Kumar, Evergreen Capital
AnsweredYes, sticking with 10–20%. Reasonably confident we will be in guided range.
Margin guidance — Pramod Kumar, Evergreen Capital
AnsweredCurrent margins much higher (20%+). 18%+ is what I would continue to guide, depending on supply chain and execution.
Aunta-Simaria deal — Pramod Kumar, Evergreen Capital
Partial₹200 Cr equity plus NCA and ₹764 Cr debt will transfer. Expected Q3 FY27 close. (Mgmt declined further details.)
Order pipeline and mix — Srika, Individual Investor
AnsweredWater primary driver of order book. Bidding on INR8,000–10,000 Cr total. Orders expected in water, rehab, tunneling by year-end/early next week.
Pune-Shirur revenue — Srika, Individual Investor
AnsweredAppointed date expected Q4 FY27. FY27 revenue: ₹300–400 Cr (post-appointed date). FY28: ₹1,000–1,200 Cr.
Guidance
FY27 consolidated revenue growth 10–20%
MediumH1 actual 11% growth (Q2: 32% w/ one-off gain, Q1: ~7–8% implied); H2 needs ~17–27% to hit range midpoint (15%). Depends on Aunta-Simaria close (Q3) and Pune-Shirur appointed date (Q4).
EBITDA margin 18%+ (maintained)
HighH1 macro EBITDA margin 33.7% (incl. ₹194 Cr Q2 gain). Core margin post-one-offs ~20–22%, well above 18% floor. Supply chain and execution cited as downside drivers.
Pune-Shirur debt sanction ₹6,334 Cr; Aunta-Simaria divestment frees capex for other projects
HighPrudent capital allocation approach: monetize mature assets (Aunta-Simaria, Mukarba), redeploy to Pune-Shirur and water treatment. No explicit capex target for FY27 given.
Risks the call surfaced
Execution delay
MediumAppointed date is lynchpin for FY27 revenue (₹300–400 Cr expected post-appt). Any delay pushes ₹1,000+ Cr FY28 target at risk. Precon 70% done; test piling commenced; but large infrastructure project history suggests slippage risk.
Order book concentration
Medium₹995 Cr of ₹2,279 Cr order book (44%) from DGT project. Mgmt claims 'roughly 3 years of revenue at current run rate' but Q2 annualized run rate (~₹4,140 Cr) means ₹995 Cr is ~9 months only. If DGT capex or timing slips, order book visibility shrinks.
Segment underperformance
MediumWMEL contributed only ₹320 Cr (16% of group) in H1 vs. ₹1,000 Cr full-year target. Mgmt attributes to timing of order releases. If order-to-revenue conversion extends beyond H2, full-year ₹1,000 Cr target at risk, risking guidance miss.
One-off dependency
Medium₹194 Cr Q2 one-off gain from Mukarba Chowk stake sale inflated Q2 PAT by 66% and revenue by 19%. Aunta-Simaria expected Q3 similarly props earnings. If Q3 close slips to Q4 or FY28, earnings momentum disrupted.
Forex / supply chain
LowChinese Commerce Ministry tunnel-boring machine export ban flagged by analyst. Mgmt confirms Herrenknecht (Germany) opened factory in Tamil Nadu; sourcing from Japan, Germany, not China. DGT capex originally in USD; reduction from $300–400 M via existing infra but FX exposure remains.
Management
Score 7/10. Clear on order book, Pune-Shirur timeline, and Aunta-Simaria close (Q3). Withheld DGT revenue/margin details citing confidentiality (reasonable). Hedged on WMEL recovery specifics but gave H2 order guidance. Transparent on one-off gains and core margin reconciliation. Delivered H1 11% growth within 10–20% guidance; no prior-year misses. Executed Mukarba Chowk 51% stake sale (₹194 Cr) in-quarter. Precon 70% on Pune-Shirur; test piling live. Order book ₹2,279 Cr on track.
1 · Q3 FY27 (Dec 2026)
Aunta-Simaria divestment expected; ₹200 Cr equity plus debt transfer
2 · Q4 FY27 (Feb–Mar 2027)
Pune-Shirur appointed date; financial close and precon completion
3 · FY28 (Apr 2027+)
Pune-Shirur revenue ramp ₹1,000–1,200 Cr; water project completions
Risk: if capex cycle delays, FY27 revenue growth likely undershoots 15% midpoint.
The ₹194 Crore Quarter: Where Growth Really Sits
Welspun reported ₹296 Cr PAT and 32% growth that looks like a breakout—until you learn ₹194 Cr is a one-off stake sale. The real story: core growth is single-digit, H1 actual is 11% YoY (well below guidance), and management held full-year guidance steady rather than raising it.
₹1,035 Cr
+32% YoY
₹194 Cr
19% of revenue
~₹841 Cr
organic ops
₹296 Cr
+201% YoY
66%
₹194 Cr gain
~₹102 Cr
+8–10% YoY
On the result card it looks like a breakout: ₹1,035 crore revenue, ₹296 crore profit, margins at 39.5%. Yet the Q2 call revealed a quarter far more nuanced than the headline suggests. Management flagged early that the profit was heavily front-loaded: two-thirds of reported PAT came from the monetization of a 51% stake in Mukarba Chowk Panipat toll road. That ₹194 crore gain is real money and forms part of the company's capital-recycling strategy, but it masks the operational story. Core revenue was ~₹841 crore, core PAT ~₹102 crore. More telling: year-to-date through September, Welspun's organic revenue growth was only 11%, well below the 15% midpoint of its 10–20% FY27 guidance range.
The one-off math
What the numbers say
H1 FY27 revenue stands at ₹1,808 crore, up 11% year-on-year. That's within the 10–20% guided band, but it sits well below the midpoint (15%), signaling the year is tracking toward the lower end. Management reiterated the guidance range with no uplift—a read that says: 'we're confident in the band, cautious on velocity.' The order book sits at ₹2,279 crore (as of Sept 30), providing roughly 18 months of revenue visibility at current run rates. However, concentration is an issue: the DGT oil & gas project with Adani accounts for ₹995 crore, or 44% of the total.
Q2 revenue ₹1,035 Cr, 32% YoY growth
Delivered ₹1,034.6 Cr; 32% growth real, but includes ₹194 Cr one-off. Core ops ~₹841 Cr.
Supported, with caveat
Q2 PAT ₹296 Cr, 201% YoY growth
Delivered ₹295.6 Cr; growth inflated by ₹194 Cr gain. Core PAT ~₹102 Cr, ~8–10% YoY.
Supported (headline), misleading
H1 revenue ₹1,808 Cr, 11% YoY; on track for guidance
Math checks out; 11% sits within 10–20% but below 15% midpoint. Q1 growth softer (~7–8% implied).
Supported
DGT order (₹995 Cr) covers ~3 years of revenue at current run rate
₹995 Cr ÷ annualized Q2 run rate (₹4,140 Cr) = ~9 months, not 3 years.
Overstated
Maintaining 18%+ EBITDA margin guidance
H1 macro EBITDA margin 33.7% (incl. one-offs); core margin ~20–22%, well above 18% floor.
Supported
What changed on this call
Management reverted FY27 revenue growth guidance from Q1's tighter 15% to the original 10–20% band—a widening that telegraphs caution. Two new catalysts came into focus: Aunta-Simaria road project divestment is now expected Q3 FY27 (₹200 crore equity value, plus ₹764 crore debt transfer), freeing capital. Pune-Shirur project's appointed date is now guided for Q4 FY27, with ₹300–400 crore revenue expected post-appointment in FY27, then ₹1,000–1,200 crore in FY28. The DGT oil & gas project with Adani has had its capital footprint trimmed by $300–400 million via reuse of existing offshore infrastructure—a favorable re-underwriting.
Order book ₹2,279 Cr; 18-month visibility with Pune-Shirur clarity
EBITDA margin 20–22% core, well above 18%+ guidance buffer
Aunta-Simaria & Mukarba divestments free capital for Pune-Shirur capex
Q2 profit 66% dependent on one-off; core PAT grows single-digit
H1 growth 11% trails 15% midpoint; trajectory softer than headline
WMEL ₹320 Cr H1 vs. ₹1,000 Cr full-year guide; 68% shortfall risk
DGT project 44% of order book; concentration and timing risk
Pune-Shirur capex financed (₹6,334 Cr committed); execution credible
Risks, ranked by holder concern
Pune-Shirur appointed date delay beyond Q4 FY27
HighAppointed date is the lynchpin for ₹300–400 Cr FY27 revenue recognition. Any slip into FY28 cascades into the ₹1,000–1,200 Cr FY28 ramp. Precon 70% done; test piling live; but large infrastructure projects slip frequently.
WMEL order-to-revenue conversion in H2
HighDivision is ₹680 Cr short of its ₹1,000 Cr FY27 target. H2 needs ~70% catch-up to stay on track. If order releases slow or pricing compresses, full-year target and group guidance both risk missing.
Order-book concentration and DGT execution
MediumDGT is ₹995 Cr of ₹2,279 Cr (44%). Management overstated it as ~3 years of revenue, but it's actually 9 months. If capex, regulatory approval, or production slips, order-book visibility shrinks materially.
Aunta-Simaria divestment slips to Q4 or FY28
MediumExpected Q3 close would free ₹200 Cr equity capital and clean up ₹764 Cr debt. Close delays disrupt the capital-recycling narrative and earnings momentum. Multiple stakeholder approvals required.
Core margin compression from 20–22% to 18% floor
LowSupply chain and execution cited as downside drivers. Current margin is healthy, but any shock (input costs, labor, TBM availability) could force guidance down.
How the street is positioned
The stock closed on November 12 at ₹710, trading above its 20-day SMA (₹671) but below its 50-day SMA (₹723)—a mixed technical setup. It sits 15.5% below its all-time high of ₹840, yet still +72% from its 52-week low of ₹412. RSI is neutral at 54.6; volume is increasing, a sign of potential re-engagement.
FIIs are slowly accumulating (up 45 basis points this quarter), a modest vote of confidence. Authum Investment & Infrastructure sold 25 lakh shares at ₹765 on September 18—a price above today's ₹710—suggesting the bulk sale was near a recent peak and likely pre-earnings disclosure. However, the buyer for those shares (Fidelity Blue Chip Growth Fund) added stock the same day at ₹740.99, indicating active rotation rather than broad institutional disdain. The takeaway: the 15% drawdown from the all-time high and mixed technicals suggest the market has priced in near-term caution, but professional investors are still rotating into the stock ahead of catalysts.
What to watch next
1 · Aunta-Simaria divestment close (Q3 FY27 expected)
If closed by December 2026, ₹200 Cr equity unlock plus ₹764 Cr debt transfer validates capital recycling and frees cash for Pune-Shirur. Any slip to Q4 or later signals deal-structure friction or approval delays.
2 · Pune-Shirur appointed date (Q4 FY27, expected Feb–Mar 2027)
Financial close and precon completion expected by March 2027. Post-appointment, ₹300–400 Cr FY27 revenue unlocks; FY28 ramp ₹1,000–1,200 Cr follows. Precon at 70%; test piling underway; slippage risk remains.
3 · WMEL H2 order releases and revenue realization
Division needs ₹680+ Cr in the next 6 months to hit ₹1,000 Cr FY27 target. Orders are 'released now, moving to convert'; execution and pricing will determine whether this bridge is crossed.
4 · DGT project (EDP approval pending with DGH)
Exploration & Development Plan submitted to Directorate General of Hydrocarbons; approval timing unclear. Capex reduction of $300–400 M already factored in. Any approval acceleration or further cost de-risk would be positive.
5 · Q3 FY27 earnings (expected January 2027)
Will confirm Aunta-Simaria one-off close or delay. Core ops momentum and order-book progression will signal confidence in FY28 ramp. WMEL ramp and pricing environment will be closely watched.
Welspun's Q2 delivered on every headline metric—revenue, margin, order book. But strip the ₹194 crore one-off and the quarter is a steady operational performance, not a step-change. Management's refusal to raise guidance despite strong reported numbers is the honest signal: core growth is moderate, catalysts are real but execution-dependent, and near-term momentum is softer than the ₹296 crore profit headline suggests.
The stock's 15% drawdown from its all-time high and mixed technicals suggest the market has already priced in near-term caution. For holders, the next 6 months are about catalyst execution: Aunta-Simaria close, Pune-Shirur appointed date, and WMEL's H2 ramp. For prospective buyers, wait for confirmation that these catalysts stick to the guidance timetable. The number to track from here is core PAT, not reported PAT—because one-offs are capital releases and wealth recycling, not repeatable earnings. If core PAT growth can hit 15%+ heading into FY28, the ₹1,000+ crore Pune-Shirur ramp will be the true inflection story. Until then, this is steady execution with optionality, not high conviction.